权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Development and Characterization of 3D Organoid Lines from Circulating Tumor Cells of African-American Prostate Cancer Patients

非裔美国前列腺癌患者循环肿瘤细胞 3D 类器官系的开发和表征

基本信息

批准号：
9273217
负责人：
Gagan Deep
金额：
$ 20万
依托单位：
WAKE FOREST UNIVERSITY HEALTH SCIENCES
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
起止时间：
2015-07-15 至 2018-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9273217
关键词：
African American Age Anabolism Area Attention B-Lymphocytes Biogenesis Biological Biological Assay Cancer Etiology Cancer Patient Caucasians Cell Line Cell Proliferation Cell Survival Cells Development Diagnosis Disease Employee Strikes Endothelial Cells Epigenetic Process Exhibits Fibroblasts Formalin Genetic Gleason Grade for Prostate Cancer Health Hypoxia Lactic acid Malignant Neoplasms Malignant neoplasm of prostate Mass Spectrum Analysis Measures Mediating Metabolic Molecular Morbidity - disease rate Neoplasm Circulating Cells Non-Malignant Organoids Outcome Oxygen Patients Phenotype Prostate Prostatectomy Proteins Public Health Role Serum Signal Pathway Socioeconomic Status Survival Rate Testing Tube Tumor Tissue exosome health disparity high risk men knock-down macrophage men mortality nanoparticle new therapeutic target outcome forecast prostate cancer cell racial disparity research study tumor microenvironment

项目摘要

DESCRIPTION (provided by applicant): Prostate cancer (PCA) exhibits the most striking racial disparity as African American men are at higher risk of being diagnosed and dying of PCA, in comparison with Caucasian men. Although, multiple factors including socio-economic status contribute to this disparity but it is essential to identify the molecular and underlying biological differences that contribute to the more aggressive phenotype in African American PCA. There have been several studies investigating the genetic and epigenetic differences between African American and Caucasian PCA; however in the past, limited attention has been given to the role of tumor microenvironment contributing towards disease aggressiveness in African American PCA. In this regard, our preliminary studies discovered a unique capability of African American PCA cells to survive under hypoxic (low oxygen condition) conditions dependent upon cellular RAB5A expression, the master regulator of exosomes biogenesis, as the survival of African American PCA cells was completely compromised in RAB5A knock-down condition. More importantly, compared to Caucasian PCA cells, African American PCA cells secreted significantly higher amount of exosomes under hypoxic conditions. Interestingly, African American PCA cells seem to better adapt to hypoxia through exporting metabolic product lactic acid packaged in exosomes. Recent studies have also provided ample evidence that lactic acid is used not only as a fuel for bioenergy and biosynthesis but lactic acid also activates several mitogenic signaling pathways in various tumor microenvironment cellular components including endothelial cells, fibroblasts, macrophages and PCA cells in the normoxic areas. Taken together, we hypothesize that "African American PCA cells have the unique capability to survive hypoxia via RAB5A-mediated exosomes secretion loaded with lactic acid, and the secreted exosomes promote extensive tumor microenvironment remodeling and disease aggressiveness'. Following specific aims are proposed to test our hypothesis: (I) to characterize and establish RAB5A role in exosomes secretion and survival of African American PCA cells under hypoxia; and (II) to examine and establish the role of exosomes secreted by African American PCA cells in tumor microenvironment remodeling. Proposed studies will bring a paradigm shift in our approach to understand and treat PCA in African American men brining greater focus on tumor microenvironment both for prognosis as well as treatment purposes. Overall, present proposal is highly significant and will help to narrow the huge health disparity gap faced by African American PCA patients, and reduce the PCA-caused mortality and morbidity in these patients.

项目成果

期刊论文数量（4）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Exosomes-based biomarker discovery for diagnosis and prognosis of prostate cancer.

DOI：
10.2741/4565
发表时间：
2017-06-01
期刊：
Frontiers in bioscience (Landmark edition)
影响因子：
0
作者：
通讯作者：

Exosomal microRNA profiling to identify hypoxia-related biomarkers in prostate cancer.

DOI：
10.18632/oncotarget.24532
发表时间：
2018-03-02
期刊：
Oncotarget
影响因子：
0
作者：
Panigrahi GK;Ramteke A;Birks D;Abouzeid Ali HE;Venkataraman S;Agarwal C;Vibhakar R;Miller LD;Agarwal R;Abd Elmageed ZY;Deep G
通讯作者：
Deep G

Dysregulated gene expression predicts tumor aggressiveness in African-American prostate cancer patients.

DOI：
10.1038/s41598-018-34637-8
发表时间：
2018-11-05
期刊：
Scientific reports
影响因子：
4.6
作者：
Ali HEA;Lung PY;Sholl AB;Gad SA;Bustamante JJ;Ali HI;Rhim JS;Deep G;Zhang J;Abd Elmageed ZY
通讯作者：
Abd Elmageed ZY

Hypoxia-Induced Signaling Promotes Prostate Cancer Progression: Exosomes Role as Messenger of Hypoxic Response in Tumor Microenvironment.